Literature DB >> 29948831

Edoxaban for the treatment of cancer associated venous thromboembolism as an alternative to low-molecular-weight-heparin.

Elisa Maria Fiorelli1, Roberta Elisa Rossi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29948831     DOI： 10.1007/s11739-018-1886-y

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

1.  Pros and cons of new oral anticoagulants in the treatment of venous thromboembolism in patients with cancer.

Authors:  Melina Verso; Giancarlo Agnelli; Paolo Prandoni
Journal:  Intern Emerg Med       Date:  2015-04-04       Impact factor: 3.397

2.  Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.

Authors:  Agnes Y Y Lee; Pieter W Kamphuisen; Guy Meyer; Rupert Bauersachs; Mette S Janas; Mikala F Jarner; Alok A Khorana
Journal:  JAMA       Date:  2015-08-18       Impact factor: 56.272

3.  Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.

Authors:  Agnes Y Y Lee; Mark N Levine; Ross I Baker; Chris Bowden; Ajay K Kakkar; Martin Prins; Frederick R Rickles; Jim A Julian; Susan Haley; Michael J Kovacs; Michael Gent
Journal:  N Engl J Med       Date:  2003-07-10       Impact factor: 91.245

Review 4.  Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.

Authors:  Elie A Akl; Lara Kahale; Maddalena Barba; Ignacio Neumann; Nawman Labedi; Irene Terrenato; Francesca Sperati; Paola Muti; Holger Schünemann
Journal:  Cochrane Database Syst Rev       Date:  2014-07-08

5.  Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.

Authors:  Gary E Raskob; Nick van Es; Peter Verhamme; Marc Carrier; Marcello Di Nisio; David Garcia; Michael A Grosso; Ajay K Kakkar; Michael J Kovacs; Michele F Mercuri; Guy Meyer; Annelise Segers; Minggao Shi; Tzu-Fei Wang; Erik Yeo; George Zhang; Jeffrey I Zwicker; Jeffrey I Weitz; Harry R Büller
Journal:  N Engl J Med       Date:  2017-12-12       Impact factor: 91.245
  5 in total
  1 in total

1.  A focus on direct oral anticoagulants: "old" and possible new indications and efforts for a better clinical management.

Authors:  Domenico Prisco
Journal:  Intern Emerg Med       Date:  2018-09-21       Impact factor: 3.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.